Postpartum Psychiatric Disorders

So Glad You Asked Podcast: Kriti Lodha and Meghan Cliffel on Postpartum Psychosis

Postpartum psychosis is uncommon but serious. In this podcast episode, survivors share early signs, treatment, and recovery—helping families and clinicians recognize and respond quickly.

By |2026-07-10T10:15:03-04:00July 8th, 2026|Podcast, Postpartum Psychiatric Disorders, Postpartum Psychosis|Comments Off on So Glad You Asked Podcast: Kriti Lodha and Meghan Cliffel on Postpartum Psychosis

Dysphoric Milk Ejection Reflex: Recognizing a Poorly Understood Breastfeeding Challenge

Dysphoric Milk Ejection Reflex causes brief, intense waves of dysphoria at milk letdown, often misinterpreted as postpartum depression, and can undermine breastfeeding and maternal well-being.

By |2026-06-29T10:24:04-04:00June 29th, 2026|Breastfeeding & Medications, Postpartum Psychiatric Disorders|Comments Off on Dysphoric Milk Ejection Reflex: Recognizing a Poorly Understood Breastfeeding Challenge

Understanding Postpartum OCD and Intrusive Thoughts: Video from Dr. Marlene Freeman

In a recent video, Dr. Marlene Freeman delivers an expert commentary on postpartum OCD, highlighting research showing intrusive thoughts are common, distressing, and not linked to infant harm.

By |2026-04-20T09:47:02-04:00April 15th, 2026|OCD, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on Understanding Postpartum OCD and Intrusive Thoughts: Video from Dr. Marlene Freeman

Pharmacologic Treatment of Postpartum Depression: What Happens in the Real World?

New data reveal that while most women with postpartum depression start antidepressant treatment, many discontinue treatment early—highlighting persistent gaps in postpartum care.

By |2026-05-21T08:01:55-04:00April 14th, 2026|Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Pharmacologic Treatment of Postpartum Depression: What Happens in the Real World?

Rapid Symptom Relief in Postpartum Psychosis with Brexanolone

An open-label pilot study suggests that intravenous brexanolone may rapidly reduce psychotic, manic, and depressive symptoms in patients with postpartum psychosis, highlighting a potential new treatment option.

By |2026-04-01T06:32:10-04:00March 31st, 2026|Antidepressants, Postpartum Depression, Postpartum Psychiatric Disorders, Postpartum Psychiatric Disorders, Postpartum Psychosis, Treatment|Comments Off on Rapid Symptom Relief in Postpartum Psychosis with Brexanolone
Go to Top